BIOPOR.CO
Price:
$1.81
Market Cap:
$806.48M
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was incorporated in 1917 and is based in Hellerup, Denmark.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2000-01-13
Stock Exchange
CPH
Ticker
BIOPOR.CO
According to BioPorto A/S’s latest financial reports and current stock price. The company's current ROE is -72.11%. This represents a change of 262.83% compared to the average of -19.87% of the last 4 quarters.
The mean historical ROE of BioPorto A/S over the last ten years is -90.79%. The current -72.11% ROE has changed -20.58% with respect to the historical average. Over the past ten years (40 quarters), BIOPOR.CO's ROE was at its highest in in the September 2015 quarter at -3.69%. The ROE was at its lowest in in the March 2020 quarter at -142.86%.
Average
-90.79%
Median
-64.36%
Minimum
-275.03%
Maximum
-24.12%
Discovering the peaks and valleys of BioPorto A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 306.21%
Maximum Annual ROE = -24.12%
Minimum Annual Increase = -77.82%
Minimum Annual ROE = -275.03%
Year | ROE | Change |
---|---|---|
2023 | -93.63% | -13.40% |
2022 | -108.12% | -12.99% |
2021 | -124.26% | 103.68% |
2020 | -61.01% | -77.82% |
2019 | -275.03% | 306.21% |
2018 | -67.70% | 17.73% |
2017 | -57.51% | 11.71% |
2016 | -51.48% | 113.38% |
2015 | -24.12% | -46.46% |
2014 | -45.06% | -6.35% |
The current ROE of BioPorto A/S (BIOPOR.CO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-108.67%
5-year avg
-132.41%
10-year avg
-90.79%
BioPorto A/S’s ROE is less than Ambu A/S (8.12%), less than Bavarian Nordic A/S (7.02%), less than SAS AB (publ) (77.06%), greater than Zealand Pharma A/S (-18.21%), greater than Orphazyme A/S (-119.01%),
Company | ROE | Market cap |
---|---|---|
8.12% | $33.92B | |
7.02% | $16.27B | |
77.06% | $88.28M | |
-18.21% | $58.67B | |
-119.01% | $46.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioPorto A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioPorto A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioPorto A/S's ROE?
How is the ROE calculated for BioPorto A/S (BIOPOR.CO)?
What is the highest ROE for BioPorto A/S (BIOPOR.CO)?
What is the 3-year average ROE for BioPorto A/S (BIOPOR.CO)?
What is the 5-year average ROE for BioPorto A/S (BIOPOR.CO)?
How does the current ROE for BioPorto A/S (BIOPOR.CO) compare to its historical average?